Triplex formation by morpholino oligodeoxyribonucleotides in the HER-2/neu promoter requires the pyrimidine motif

Nucleic Acids Research

Volumn 29, Issue 23, 2001, Pages 4873-4880

  Basye, Jenny ^a   Trent, John O ^b   Gao, Daquan ^b   Ebbinghaus, Scot W ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM; MORPHOLINE DERIVATIVE; NUCLEASE; OLIGODEOXYRIBONUCLEOTIDE; POTASSIUM ION; PURINE; PYRIMIDINE;

ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE SEQUENCE; GENE TARGETING; GENE THERAPY; MOLECULAR MODEL; ONCOGENE NEU; PH; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MOTIF; SEQUENCE HOMOLOGY; TRIPLE HELIX;

EID: 0035581120     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/29.23.4873     Document Type: Article

References (43)

1. Specific regulation of gene expression by antisense, sense and antigene nucleic acids
2. Control of oncogene expression by antisense nucleic acids
3. Antisense oligonucleotides as therapeutic agents-is the bullet really magical?
4. Gene inhibition using antisense oligodeoxynucleotides
5. Sequence-specific recognition, photocrosslinking and cleavage of the DNA double helix by an oligo-α-thymidylate covalently linked to an azidoproflavine derivative
6. Sequence-specific cleavage of double helical DNA by triple helix formation
7. Extension of the range of recognition sequences for triple helix formation by oligonucleotides containing guanines and thymines
8. Modulation of Cm/T, G/A and G/T triplex stability by conjugate groups in the presence and absence of KCl
9. Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3′ exonuclease in plasma
10. Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells
11. A specificity comparison of four antisense types: Morpholino, 2′-O-methyl RNA, DNA and phosphorothioate DNA
12. Morpholino and phosphorothioate antisense oligomers compared in cell-free and in-cell systems
13. Morpholino antisense oligomers: Design, preparation and properties
14. Resistance of morpholino phosphorodiamidate oligomers to enzymatic degradation
15. Evaluation of antisense mechanisms of action
16. Antisense morpholino oligonucleotide analog induces missplicing of C-myc mRNA
17. Intracellular delivery strategies for antisense phosphorodiamidate morpholino oligomers
18. Pyrimidine morpholino oligonucleotides form a stable triple helix in the absence of magnesium ions
19. Kinetics and thermodynamics of triple-helix formation: Effects of ionic strength and mismatches
20. Kinetic analysis of oligodeoxyribonucleotide-directed triple-helix formation on DNA
21. Equilibrium association constants for oligonucleotide-directed triple helix formation at single DNA sites: Linkage to cation valence and concentration
22. The integral divalent cation within the intermolecular purine*purine.pyrimidine structure: A variable determinant of the potential for and characteristics of the triple helical association
23. Transport across cell membranes
24. Formation of a parallel-stranded DNA homoduplex by d(GGA) repeat oligonucleotides
25. Overcoming potassium-mediated triplex inhibition
26. A new approach to overcome potassium-mediated inhibition of triplex formation
27. Potassium-resistant triple helix formation and improved intracellular gene targeting by oligodeoxyribonucleotides containing 7-deazaxanthine
28. Divalent transition metal cations counteract potassium-induced quadruplex assembly of oligo(dG) sequences
29. Triplex formation inhibits HER-2/neu transcription in vitro
30. Inhibition of transcription factor binding to the HER2 promoter by triplex-forming oligodeoxyribonucleotides
31. An anti-parallel triple helix motif with oligodeoxynucleotides containing 2′-deoxyguanosine and 7-deaza-2′-deoxyxanthosine
32. Triple helix formation by (G,A)-containing oligonucleotides: Asymmetric sequence effect
33. General atomic and molecular-electronic structure system
34. Symmetry and structure of RNA and DNA triple helices
35. Symmetry and molecular structure of a DNA triple helix: d(T)n.d(A)n.d(T)n
36. A second generation force field for the simulation of proteins, nucleic acids and organic molecules
37. Triplex formation of chemically modified homopyrimidine oligonucleotides: Thermodynamic and kinetic studies
38. Propynylated phosphodiester oligonucleotides inhibit ICAM-1 expression in A549 cells on electroporation
39. DNA triplex formed by d-A-(G-A)7-G and d-mC-(T-mC)7-T in aqueous solution at neutral pH
40. Structural features and stability of an RNA triple helix in solution
41. Relative stabilities of triple helices composed of combinations of DNA, RNA and 2′-O-methyl-RNA backbones: Chimeric circular oligonucleotides as probes
42. Comparative stability of eight different triple helices formed by differently modified DNA or RNA pyrimidine strands and a DNA hairpin
43. Oligonucleotide N3′→P5′ phosphoramidates as potential therapeutic agents